Clinical Trials Logo

Clinical Trial Summary

Unhealthy alcohol use is a major contributor to morbidity and mortality in the US. Although effective prevention for unhealthy alcohol use and medication treatment for alcohol use disorders (AUDs) can be provided in primary care (PC), they have historically not been included in routine services. As a result, most patients do not receive evidence-based prevention or treatment for unhealthy alcohol use. Several efforts have successfully implemented alcohol-related preventive care-referred to as screening and brief intervention (SBI), but efforts to increase treatment of AUDs with medications have been less successful. Moreover, implementation efforts have usually neglected smaller PC practices, in which most PC is provided. The Michigan SPARC trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, bringing extensive expertise implementing evidence-based alcohol-related care, and Altarum Institute in Ann Arbor, Michigan, bringing demonstrated success engaging over 500 small to medium Michigan-based PC practices in effective quality improvement (QI) efforts. The project builds on Altarum's innovative approach to implementing new or improved clinical care using practice facilitators to provide continuing medical education and maintenance of certification (CME/MOC) programs to PC providers, along with ongoing support for QI using evidence-based implementation strategies. The KPWHRI team recently finished the highly successful AHRQ-funded Sustained Patient-centered Alcohol-Related Care (SPARC) trial using similar implementation strategies in KP Washington, including use of electronic health records and performance monitoring and feedback, and also developed a patient decision aid to support shared decision-making between patients with high-risk drinking and/or AUDs and their PC providers. The Michigan SPARC trial combines Altarum's expertise in QI in small-medium PC practices in Michigan with KPWHRI's expertise implementing evidence-based prevention and treatment of unhealthy alcohol use-specifically alcohol SBI and medication treatment for AUDs. Specific Aims of the Michigan SPARC trial are to: 1. Test whether the Michigan SPARC model increases (a) alcohol SBI and/or (b) initiation of medication treatment for AUDs, in small to medium PC practices in Michigan, in a stepped-wedge trial with 6 waves, and 2. Test whether adding an innovative decision aid for AUDs to Michigan SPARC implementation increases rates of (a) SBI, and/or (b) initiation of medication treatment for AUDs, in a nested two-arm cluster randomized trial (with 1:1 randomization within each wave).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04861792
Study type Interventional
Source Kaiser Permanente
Contact Katharine Bradley, MD, MPH
Phone 206-287-2151
Email [email protected]
Status Recruiting
Phase N/A
Start date May 1, 2021
Completion date November 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04618653 - Comprehensive Process Model of AA-related Behavior Change
Not yet recruiting NCT04828577 - Real-Time fMRI to Enhance Interventions That Change Delay Discounting N/A
Active, not recruiting NCT04639895 - Cognitive Rehabilitation Through Personalized Virtual Reality and Paper-and-pencil Interventions in the Alcohol Use Disorder Treatment. N/A
Not yet recruiting NCT04598399 - Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder N/A
Completed NCT02911285 - NAC for Treating Comorbid PTSD and SUD Phase 2
Recruiting NCT03736343 - Impulsivity and Alcohol Response Early Phase 1
Not yet recruiting NCT04229095 - Medication Development in Alcoholism: Suvorexant Versus Placebo Phase 2
Completed NCT04648423 - Evaluation of the Efficacy of Sodium Oxybate in the Long-term Maintenance of Abstinence in Alcoholic Patients Phase 4
Not yet recruiting NCT04366505 - Modification of Cue Reactivity by Neurofeedback in Human Addiction N/A
Completed NCT02371889 - A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers Phase 2
Not yet recruiting NCT04718792 - Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study Phase 2
Recruiting NCT04832321 - Measuring Beliefs and Norms About Persons With Alcohol Use Disorder N/A
Recruiting NCT02233868 - Brain Inflammation and Function in Alcoholism Early Phase 1
Recruiting NCT04822987 - Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs)
Terminated NCT03059082 - A Critical Illness Recovery Navigator for Alcohol N/A
Recruiting NCT04135846 - Alpha-1 Blockade for Alcohol Use Disorder (AUD) Phase 2
Active, not recruiting NCT04498988 - Volitional Dysfunction in Self-control Failures and Addictive Behaviors
Not yet recruiting NCT04827056 - Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study Phase 1